Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
dipyridamole | Homo sapiens (human) | AC50 | 4.0300 | 1 | 0 |
dipyridamole | Homo sapiens (human) | Max_Activity_Concentration_uM | 50.0000 | 1 | 0 |
fusaric acid | Homo sapiens (human) | Max_Activity_Concentration_uM | 0.3800 | 1 | 0 |
ns 1619 | Homo sapiens (human) | Max_Activity_Concentration_uM | 26.0000 | 1 | 0 |
alizarin | Homo sapiens (human) | AC50 | 52.0000 | 1 | 0 |
alizarin | Homo sapiens (human) | Max_Activity_Concentration_uM | 26.0000 | 1 | 0 |
5-amino-2-naphthalenesulfonate | Homo sapiens (human) | Max_Activity_Concentration_uM | 12.0000 | 1 | 0 |
2,4-dihydroxybenzophenone | Homo sapiens (human) | AC50 | 11.1300 | 1 | 0 |
2,4-dihydroxybenzophenone | Homo sapiens (human) | Max_Activity_Concentration_uM | 6.0000 | 1 | 0 |
3-aminofluoranthene | Homo sapiens (human) | AC50 | 2.0100 | 1 | 0 |
3-aminofluoranthene | Homo sapiens (human) | Max_Activity_Concentration_uM | 50.0000 | 1 | 0 |
3-aminofluoranthene | Homo sapiens (human) | Max_Concentration(uM) | 6.0000 | 1 | 0 |
s-2678 | Homo sapiens (human) | AC50 | 52.0000 | 1 | 0 |
s-2678 | Homo sapiens (human) | Max_Activity_Concentration_uM | 50.0000 | 1 | 0 |
s-2678 | Homo sapiens (human) | Max_Concentration(uM) | 50.0000 | 1 | 0 |
topotecan hydrochloride | Homo sapiens (human) | AC50 | 3.7000 | 1 | 0 |
topotecan hydrochloride | Homo sapiens (human) | Max_Activity_Concentration_uM | 0.3800 | 1 | 0 |
coumarin 153 | Homo sapiens (human) | AC50 | 2.8000 | 1 | 0 |
coumarin 153 | Homo sapiens (human) | Max_Activity_Concentration_uM | 1.6000 | 1 | 0 |
agroclavine | Homo sapiens (human) | AC50 | 38.4100 | 1 | 0 |
agroclavine | Homo sapiens (human) | Max_Activity_Concentration_uM | 50.0000 | 1 | 0 |
brazilin | Homo sapiens (human) | Max_Activity_Concentration_uM | 0.3800 | 1 | 0 |
raubasine | Homo sapiens (human) | AC50 | 52.0000 | 1 | 0 |
raubasine | Homo sapiens (human) | Max_Activity_Concentration_uM | 26.0000 | 1 | 0 |
n,n-dimethyldaunorubicin | Homo sapiens (human) | AC50 | 52.0000 | 1 | 0 |
n,n-dimethyldaunorubicin | Homo sapiens (human) | Max_Activity_Concentration_uM | 50.0000 | 1 | 0 |
doxorubicin hydrochloride | Homo sapiens (human) | AC50 | 43.4100 | 1 | 0 |
doxorubicin hydrochloride | Homo sapiens (human) | Max_Activity_Concentration_uM | 50.0000 | 1 | 0 |
3-[3,4-dihydro-1H-isoquinolin-2-yl-[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]-7-methoxy-1H-quinolin-2-one | Homo sapiens (human) | Max_Activity_Concentration_uM | 6.0000 | 1 | 0 |
3-[3,4-dihydro-1H-isoquinolin-2-yl-[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]-7-methoxy-1H-quinolin-2-one | Homo sapiens (human) | Max_Concentration(uM) | 26.0000 | 1 | 0 |
N-(2-oxolanylmethyl)-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine | Homo sapiens (human) | Max_Activity_Concentration_uM | 0.8000 | 1 | 0 |
2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid hexyl ester | Homo sapiens (human) | Max_Activity_Concentration_uM | 0.8000 | 1 | 0 |
N-(4-amino-2-oxo-1-benzopyran-3-yl)acetamide | Homo sapiens (human) | Max_Activity_Concentration_uM | 0.8000 | 1 | 0 |
N-(4-amino-2-oxo-1-benzopyran-3-yl)acetamide | Homo sapiens (human) | Max_Concentration(uM) | 50.0000 | 1 | 0 |
3-amino-N-(2-fluorophenyl)-6-(phenylmethyl)-4-(trifluoromethyl)-2-thieno[2,3-b]pyridinecarboxamide | Homo sapiens (human) | Max_Activity_Concentration_uM | 12.0000 | 1 | 0 |
2-[[2-[(3,7-dimethyl-2-quinolinyl)thio]-1-oxoethyl]amino]-4,5-dimethoxybenzoic acid | Homo sapiens (human) | Max_Activity_Concentration_uM | 3.0000 | 1 | 0 |
2-[[2-[(3,7-dimethyl-2-quinolinyl)thio]-1-oxoethyl]amino]-4,5-dimethoxybenzoic acid | Homo sapiens (human) | Max_Concentration(uM) | 50.0000 | 1 | 0 |
N-(3-chlorophenyl)-2-[[2-(2-pyridinyl)-2,3-dihydro-1,3,4-thiadiazol-5-yl]thio]acetamide | Homo sapiens (human) | Max_Activity_Concentration_uM | 3.0000 | 1 | 0 |
2-(3-hydroxyphenyl)-6-(1-piperidinyl)benzo[de]isoquinoline-1,3-dione | Homo sapiens (human) | Max_Activity_Concentration_uM | 0.8000 | 1 | 0 |
2-(3-hydroxyphenyl)-6-(1-piperidinyl)benzo[de]isoquinoline-1,3-dione | Homo sapiens (human) | Max_Concentration(uM) | 50.0000 | 1 | 0 |
6-amino-3-methyl-4-(2-methylpropyl)-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | Homo sapiens (human) | Max_Activity_Concentration_uM | 0.3800 | 1 | 0 |
6-amino-3-methyl-4-(2-methylpropyl)-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | Homo sapiens (human) | Max_Concentration(uM) | 50.0000 | 1 | 0 |
LSM-24581 | Homo sapiens (human) | Max_Activity_Concentration_uM | 0.3800 | 1 | 0 |
LSM-24581 | Homo sapiens (human) | Max_Concentration(uM) | 50.0000 | 1 | 0 |
(1S,2R)-2-[[(1S)-1-[(1,3-dioxo-2-isoindolyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-oxomethyl]-1-cyclohexanecarboxylic acid | Homo sapiens (human) | AbsAC40_uM | 13.1850 | 1 | 0 |
(1S,2R)-2-[[(1S)-1-[(1,3-dioxo-2-isoindolyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-oxomethyl]-1-cyclohexanecarboxylic acid | Homo sapiens (human) | AC50 | 2.4967 | 3 | 0 |
(1S,2R)-2-[[(1S)-1-[(1,3-dioxo-2-isoindolyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-oxomethyl]-1-cyclohexanecarboxylic acid | Homo sapiens (human) | Max_Delta_Tm_Conc_uM | 19.5000 | 1 | 0 |